Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px
All >

News > Western Europe

Please find below news about Austria, Belgium, France, Germany, Liechtenstein, Luxembourg, Monaco, the Netherlands and Switzerland as well as about organisations from these countries.

Total search results: 6259 | Ordered by Date (descending)
1 2 3 ... 61 62 63  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Mainz Biomed N.V.. (1/27/22). "Press Release: Mainz Biomed Appoints Steve Quinn as VP Business Development". Berkeley & Mainz. 2022-01-27
Galapagos N.V.. (1/26/22). "Press Release: Galapagos Appoints Paul Stoffels as Chief Executive Officer". Mechelen. 2022-01-26
Evotec SE. (1/25/22). "Press Release: Evotec Enters iPSC-based Drug Discovery Partnership with Boehringer Ingelheim in Ophthalmology". Hamburg. 2022-01-25
Leyden Laboratories B.V.. (1/25/22). "Press Release: Leyden Labs Raises $200M in 2021 for a New Approach to Combat Viruses". Amsterdam & Boston, MA. 2022-01-25
InstaDeep. (1/25/22). "Press Release: InstaDeep Raises $100M to Scale Decision-Making AI Products that Solve Real-World Problems". London. 2022-01-25
genOway S.A.. (1/25/22). "Press Release: genOway Grants the Leading UK Academic Research Funder a Non-exclusive License for CRISPR/Cas9 Technology". Lyon. 2022-01-25
Cyprumed GmbH. (1/24/22). "Press Release: Cyprumed GmbH Enters Agreement with Ferring Pharmaceuticals for Development of Oral Drug Delivery Technology for Patient-Centric non-invasive Peptide Therapeutics". Innsbruck. 2022-01-24
Marinomed Biotech AG. (1/21/22). "Press Release: Marinomed Announces the Appointment of Dr. Cornelia Kutzer as Chief Business Officer". Korneuburg. 2022-01-21
Centogene N.V.. (1/20/22). "Press Release: Centogene Joins Forces with Insilico Medicine for Niemann-Pick Disease Type C (NPC) Target Discovery, Applying Artificial Intelligence (AI) to Accelerate Orphan Drug Development". Cambridge, MA, Rostock & Berlin 2022-01-20
Argenx SE. (1/20/22). "Press Release: Argenx Announces Vyvgart Approval in Japan for the Treatment of Generalized Myasthenia Gravis". Breda. 2022-01-20
Bruker Corporation. (1/19/22). "Press Release: Bruker Acquires Prolab Instruments to Augment Multiomics Solutions". Billerica, MA. 2022-01-19
UCB S.A.. (1/19/22). "Press Release: UCB to Acquire Zogenix". Brussels & Emeryville, CA. 2022-01-19
77 Foods S.A.S. (d/b/a La Vie Foods). (1/19/22). "Press Release: The Start-up La Vie Raises €25M and Sets Out to Conquer the World with Its New Generation of Plant-based Meat". Paris. 2022-01-19
EOS GmbH. (1/19/22). "Press Release: EOS Launches End-To-End Production Network". Krailing. 2022-01-19
TVM Capital Life Science. (1/18/22). "Press Release: TVM Capital Life Science Promotes Dr. Sascha Berger and Dr. Alain Thibault to General Partner". Munich & Montréal. 2022-01-18
PreOmics GmbH. (1/18/22). "Press Release: PreOmics Announces Closing of Series B Financing to Accelerate Research, Development and Commercialization of Proteomics Tools and Consumables". Munich. 2022-01-18
Planet B.io. (1/18/22). "Press Release: Planet B.io Becomes Shareholder of the Bioprocess Pilot Facility". 2022-01-18
Inova Software S.A.S.. (1/18/22). "Press Release: Inova Acquires Leading European Biotech News Media Company, Labiotech". Lyon. 2022-01-18
Leyden Laboratories B.V.. (1/18/22). "Press Release: Leyden Labs Licenses Pan-Influenza Antibody from Janssen". Amsterdam & Boston, MA. 2022-01-18
Neurimmune AG. (1/17/22). "Press Release: Neurimmune Expands Drug Discovery Collaboration with Ono Pharmaceutical in the Field of Neurodegenerative Diseases". Zürich. 2022-01-17
Indivumed GmbH. (1/17/22). "Press Release: Accelerated Drug Development and Personalised Treatments for Cancer. Indivumed Receives EU Funding from ERDF Structural Fund". Hamburg. 2022-01-17
Relief Therapeutics Holding AG. (1/14/22). "Press Release: Relief Therapeutics Comments on NRx Pharmaceuticals' Press Release Reporting on its Recently Filed Lawsuit". Geneva. 2022-01-14
ITM Isotope Technologies Munich SE. (1/13/22). "Press Release: ITM and Helmholtz Munich Sign Cooperation Agreement for the Clinical Development of Radiopharmaceutical Therapy to Treat Glioblastoma Multiforme". Garching. 2022-01-13
ProtaGene GmbH. (1/12/22). "Press Release: Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene". Heilbronn, Heidelberg & Boston, MA. 2022-01-12
Temedica GmbH. (1/12/22). "Press Release: Temedica Introduces Permea. First Analytics Platform Integrating Patient-Generated Health Data". Munich. 2022-01-12
Lumicks Technologies B.V.. (1/12/22). "Press Release: Lumicks Announces the Installation of its Quadruple C-Trap® Instrument at Rockefeller University to Expand Fundamental Research of DNA Processes". Amsterdam. 2022-01-12
Relief Therapeutics Holding AG. (1/12/22). "Press Release: Relief Comments on Lawsuit Filed Against It by NeuroRx". Geneva. 2022-01-12
Creoptix AG. (1/11/22). "Press Release: Malvern Panalytical Expands Pharmaceutical Drug Development Solutions through the Acquisition of Creoptix". 2022-01-11
Pantherna Therapeutics GmbH. (1/11/22). "Press Release: Pantherna Therapeutics Secures EUR 4.0 Mio. Follow-on Financing to Advance Its Therapeutic mRNA Development Programs". Hennigsdorf. 2022-01-11
BioNTech SE. (1/11/22). "Press Release: BioNTech and InstaDeep Developed and Successfully Tested Early Warning System to Detect Potential High-Risk SARS-CoV-2 Variants". Mainz & London. 2022-01-11
Xlife Sciences AG. (1/10/22). "Press Release: Xlife Sciences Plans Listing on the »Sparks« Segment of SIX Swiss Exchange". Zürich. 2022-01-10
Mammoth Biosciences, Inc.. (1/10/22). "Press Release: Bayer and Mammoth Biosciences to Collaborate on Novel Gene Editing Technology". Berlin & Brisbane, CA. 2022-01-10
BioNTech SE. (1/10/22). "Press Release: BioNTech and Crescendo Biologics Announce Global Collaboration to Develop Multi-specific Precision Immunotherapies". Mainz & Cambridge. 2022-01-10
Molecular Partners AG. (1/10/22). "Press Release: Molecular Partners and Novartis Report Positive Topline Data from Phase 2 Study for Ensovibep (MP0420), a DARPin Antiviral Therapeutic for COVID-19". Zürich-Schlieren & Concord, MA. 2022-01-10
Electrochaea GmbH. (1/7/22). "Press Release: Growth-Stage Power-to-Gas Company Electrochaea Closes Series D Financing Round". Munich. 2022-01-07
Neurimmune AG. (1/7/22). "Press Release: Neurimmune Enters into a Collaboration and License Agreement with AstraZeneca to Develop and Commercialize NI006". Zürich. 2022-01-07
Exscientia plc. (1/7/22). "Press Release: Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines". Paris, Oxford & Boston, MA. 2022-01-07
Novartis AG. (1/6/22). "Press Release: Novartis Announces Collaboration with Alnylam to Explore Targeted Therapy to Restore Liver Function". Basel. 2022-01-06
Merck KGaA. (1/6/22). "Press Release: Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA". Darmstadt. 2022-01-06
ITM Isotope Technologies Munich SE. (1/5/22). "Press Release: ITM Isotope Technologies Munich to Present at the 40th Annual J.P. Morgan Healthcare Conference". Garching. 2022-01-05
BioNTech SE. (1/5/22). "Press Release: Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine". New York, NY & Mainz. 2022-01-05
DNA Script. (1/4/22). "Press Release: DNA Script Closes $200 Million Series C Financing with Completion of Second Tranche". South San Francisco, CA & Paris. 2022-01-04
Spectro Analytical Instruments GmbH. (1/4/22). "Press Release: Change in Spectro Management – Michael Privik Succeeds Dr. Christoph Mätzig". Kleve. 2022-01-04
Santhera Pharmaceuticals Holding AG. (1/4/22). "Press Release: Santhera Enters into Exclusive License Agreement with Sperogenix for Vamorolone in Rare Diseases in the Greater China Region". Pratteln. 2022-01-04
Evotec SE. (1/3/22). "Press Release: Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic". Hamburg. 2022-01-03
Noxxon Pharma N.V.. (1/3/22). "Press Release: Noxxon Secures €17 Million Expansion of Equity-linked Facility with Atlas to Advance NOX-A12 in Glioblastoma and Pancreatic Cancer Programs [ corrected version of press release originally issued 29 Dec 2021 ] 2022-01-03
Onxeo S.A.. (1/3/22). "Press Release: Onxeo Appoints Julien Miara as New Interim CEO". Paris. 2022-01-03
ITM Isotope Technologies Munich SE. (12/27/21). "Press Release: ITM and Grand Pharma Enter into a Commercialization Agreement for Targeted Radiopharmaceuticals in the Greater China Area". Garching & Hong Kong. 2021-12-27
Evolva Holding S.A.. (12/27/21). "Press Release: Evolva Secures Additional Financing Lines to Accelerate Its Growth". Reinach. 2021-12-27
Novartis AG. (12/22/21). "Press Release: Novartis to Acquire Gyroscope Therapeutics, Adding a One-time Gene Therapy that Could Transform Care for Geographic Atrophy, a Leading Cause of Blindness". Basel. 2021-12-22
Antigon S.A.. (12/22/21). "Press Release: Antigon Raises €1.5m to CE Mark Portable Blood Transfusion Security Device ISABO". Gosselies. 2021-12-22
Sanofi S.A.. (12/21/21). "Press Release: Sanofi to Acquire Amunix Immuno-oncology Pipeline with Next Generation Conditionally Activated Biologics". Paris. 2021-12-21
Thuja Capital Management. (12/21/21). "Press Release: Thuja Announces the Final Close of Thuja Capital Healthcare Fund III at EUR 76M (USD 86M)". Utrecht. 2021-12-21
Argenx SE. (12/20/21). "Press Release: Argenx Announces U.S. Food and Drug Administration (FDA) Approval of Vyvgart (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis". Darmstadt. 2021-12-20
Novartis AG. (12/20/21). "Press Release: Novartis Strengthens Immunotherapy Pipeline with Option, Collaboration and License Agreement with BeiGene for TIGIT inhibitor Ociperlimab". Basel. 2021-12-20
Merck KGaA. (12/20/21). "Press Release: Merck Expands Neuroinflammatory Pipeline with Acquisition of Chord Therapeutics [ Not intended for UK and US based media ]". Darmstadt. 2021-12-20
NorthSea Therapeutics B.V.. (12/17/21). "Press Release: NorthSea Therapeutics Completes US$80 Million Series C Fundraising to Advance Clinical Programs in Metabolic Disorders". Amsterdam. 2021-12-17
Genfit S.A.. (12/17/21). "Press Release: Ipsen and Genfit Enter into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-term Global Partnership". Paris. 2021-12-17
Synerkine Pharma B.V.. (12/16/21). "Press Release: Synerkine Pharma Raises EUR 3.5 Million in an Extended Series A Financing". Naarden. 2021-12-16
Metrion Biosciences Ltd.. (12/16/21). "Press Release: Metrion Biosciences and Bioqube Ventures Collaborate on Venture Creation Project to Identify novel ion channel inhibitors for autoimmune diseases". Cambridge & Brussels. 2021-12-16
Argobio S.A.S.. (12/16/21). "Press Release: Argobio and GeneCode Partner on Parkinson’s Disease in Argobio’s First Announced Research Agreement". Paris & Tallinn. 2021-12-16
Evotec SE. (12/16/21). "Press Release: Evotec Receives US$ 18 m Grant for Women’s Health". Hamburg. 2021-12-16
Sartorius AG. (12/16/21). "Press Release: Sartorius Strengthens Its Bioanalytics Portfolio by Acquiring a Majority Stake in ALS Automated Lab Solutions". Göttingen. 2021-12-16
Anaveon AG. (12/16/21). "Press Release: Anaveon to Raise CHF 110 Million in Oversubscribed Series B Financing". Basel. 2021-12-16
Depixus S.A.S.. (12/15/21). "Press Release: Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing". Paris & Cambridge. 2021-12-15
Agilent Technologies Inc.. (12/15/21). "Press Release: Lonza and Agilent Announce Strategic Collaboration to Integrate New Analytical Technologies with Lonza’s Cocoon Platform". Basel & Santa Clara, CA. 2021-12-15
Bico Group AB. (12/15/21). "Press Release: Cellink and Nanoscribe Join Forces to Launch the Quantum X bio, the World’s Most Accurate 3D Bioprinter". 2021-12-15
Molecular Partners AG. (12/14/21). "Press Release: Molecular Partners Announces Collaboration with Novartis to Develop DARPin-conjugated Radioligand Therapeutic Candidates for Oncology". Schlieren. 2021-12-14
CellCarta. (12/14/21). "Press Release: CellCarta Acquires Biogazelle to Strengthen Its Genomic Capabilities and Expand into Digital PCR (dPCR) Services". Montréal. 2021-12-14
Mainz Biomed N.V.. (12/14/21). "Press Release: Mainz Biomed Expands ColoAlert Commercialization with Ganzimmun Diagnostics in Europe". Berkeley, CA & Mainz. 2021-12-14
Sirius Medical Systems B.V.. (12/14/21). "Press Release: Sirius Medical Announces Second Closing of A-Round Financing". 2021-12-14
Wacker Chemie AG. (12/14/21). "Press Release: Wacker and CordenPharma Develop Solutions for Formulating Lipid Nanoparticles Expanding Their Portfolio for Advanced Medicines". Munich & Luxembourg. 2021-12-14
Ryvu Therapeutics S.A.. (12/14/21). "Press Release: Ryvu Announces Option to License Inflammation Program Exercised by Galapagos NV". Tübingen, Houston, TX & New York, NY. 2021-12-14
Vifor Pharma AG. (12/14/21). "Press Release: CSL Limited Announces Tender Offer to Acquire Vifor Pharma Ltd (ad hoc)". St. Gallen. 2021-12-14
Gilde Healthcare Partners. (12/14/21). "Press Release: Philips Acquires Gilde Portfolio Company Vesper Medical to Further Expand Its Image-guided Therapy Devices Portfolio". Amsterdam & Utrecht. 2021-12-14
Immatics N.V.. (12/14/21). "Press Release: Immatics and Bristol Myers Squibb Enter into Global Exclusive License for Immatics’ TCR Bispecific Program IMA401". Tübingen, Houston, TX & New York, NY. 2021-12-14
Memo Therapeutics AG. (12/13/21). "Press Release: Memo Therapeutics AG to Receive CHF 10.5 Million from Swiss Federal Funding Programme to Clinically Develop SARS-CoV-2 Antibody Against COVID-19". Schlieren. 2021-12-13
Indivumed GmbH. (12/12/21). "Press Release: Indivumed Appoints Dr. Stephan Schüller as CFO". 2021-12-12
PBD Biotech Ltd.. (12/10/21). "Press Release: Jane Theaker Appointed as New CEO as PBD Biotech Gears Up for Next Phase of Development". 2021-12-10
Uniqure N.V.. (12/9/21). "Press Release: Uniqure and CSL Behring Announce Primary Endpoint Achieved in HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B". Lexington, MA, Amsterdam & King of Prussia, PA. 2021-12-09
Anavo Therapeutics B.V.. (12/9/21). "Press Release: Anavo Therapeutics Announces the Appointment of Charles McDermott as Chairman of the Board". Leiden & Heidelberg. 2021-12-09
Apogenix AG. (12/9/21). "Press Release: Apogenix Receives €20.7 Million in Public Funding for Pivotal Study and Preparation for Market Production of Asunercept for the Treatment of COVID-19". Heidelberg. 2021-12-09
Alloy Therapeutics. (12/9/21). "Press Release: Alloy Therapeutics Acquires deepCDR Biologics to Bring Bioinformatics and Machine Learning to its Antibody Discovery Offering". Boston, MA & Basel. 2021-12-09
Corteria Pharmaceuticals S.A.S.. (12/9/21). "Press Release: Corteria Pharmaceuticals Announces Closing of €12M Seed Financing to Advance Portfolio Assets". Paris. 2021-12-09
Forbion Capital Partners. (12/9/21). "Press Release: Forbion European Acquisition Corp. Announces Pricing of $110 Million Initial Public Offering". Naarden. 2021-12-09
Wacker Chemie AG. (12/8/21). "Press Release: Aleph Farms and Wacker Develop Open Supply Chain Solution for Proteins Used in Large-Scale Production of Cultivated Meat". Munich & Rehovot. 2021-12-08
Merck KGaA. (12/8/21). "Press Release: Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million". Darmstadt. 2021-12-08
Freenome, Inc.. (12/7/21). "Press Release: Freenome Raises $300M in Series D Financing to Advance Multiomics Platform for Early Cancer Detection". South San Francisco, CA. 2021-12-07
Emergence Therapeutics AG. (12/7/21). "Press Release: Emergence Therapeutics Raises €87 Million Series A Financing to Advance Nectin-4 ADC". Duisburg. 2021-12-07
SGS S.A.. (12/7/21). "Press Release: SGS Announces the Acquisition of Quay Pharmaceuticals Limited". 2021-12-07
AdBio Partners S.A.S.. (12/7/21). "Press Release: Advent France Biotechnology Becomes AdBio Partners". Paris. 2021-12-07
HypnoVR S.A.S.. (12/7/21). "Press Release: HypnoVR Raises €4.5 Million to Accelerate the Roll Out of Its Digital Therapy Treating Pain and Anxiety". Strasbourg. 2021-12-07
Recursion Pharmaceuticals, Inc.. (12/6/21). "Press Release: Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search Capabilities". Salt Lake City, UT. 2021-12-06
Sotio Biotech a.s.. (12/2/21). "Press Release: Sotio Secures €280m of Funding to Expand and Advance Clinical Pipeline". Prague, Basel & Cambridge, MA. 2021-12-02
UCB S.A.. (12/2/21). "Press Release: UCB Announces Global Partnership to Bring Disease-modifying Therapies to People Living with Parkinson’s Disease". Brussels. 2021-12-02
Sanofi S.A.. (12/1/21). "Press Release: Sanofi to Acquire Origimm Biotechnology in First Move to Treat Acne with Vaccine-based Immunotherapy". Paris & Vienna. 2021-12-01
Amarna Therapeutics B.V.. (12/1/21). "Press Release: Amarna Therapeutics Secures Additional €5 ($5.7) Million to Advance Its Transformative Gene Therapy Platform towards Clinical Trials". Leiden. 2021-12-01
Roche. (12/1/21). "Press Release: Roche Completes Purchase Agreement with Long-term Partner TIB Molbiol to Expand PCR-test Portfolio in the Fight against New Infectious diseases". Basel. 2021-12-01
Xlife Sciences AG. (12/1/21). "Press Release: Xlife Sciences AG (XLS DE) Appoints New Chief Financial Officer". Zürich. 2021-12-01
Novalix S.A.S.. (11/30/21). "Press Release: Novalix Signs Partnership Agreement to Design and Screen Sanofi’s New DNA-Encoded Libraries". Strasbourg. 2021-11-30
1 2 3 ... 61 62 63  next pagenext page



Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

» top